Log In or Register to Join The Conversation!
Viewing 0 reply threads
  • Author
    Posts
    • #20208

      Director of Multichannel Content for Pulmonary Fibrosis News, Michael Morale, discusses an Australian study that suggests that antacid therapy may not benefit IPF patients or impact outcomes.

      What are your thoughts about this study and its findings?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.
Copyright © 2017-2020 All rights reserved.

©2020 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account